Akums Drugs & Pharmaceuticals Ltd.

Financial

	Akums Drugs & Pharma	Aarti Pharmalabs	Shilpa Medicare
Operational Metrics
Pharmaceutical Sector
DMF Filingsby API	20.0 .	n/a	n/a
R&D as a % of Total Sales	0.7 %	n/a	2.69 %
Financials
5 yr Average ROE	-0.59 %	7.89 %	5.0 %
5yr average Equity Multiplier	3.58	1.37	1.64
5yr Average Asset Turnover Ratio	1.18	0.54	0.39
5yr Avg Net Profit Margin	1.67 %	7.96 %	7.72 %
Price to Book	2.66	3.94	3.53
P/E	23.96	28.8	107.07
5yr Avg Cash Conversion Cycle	41.09 Days	89.79 Days	76.54 Days
Inventory Days	60.56 Days	92.09 Days	105.79 Days
Days Receivable	71.09 Days	95.5 Days	113.53 Days
Days Payable	82.93 Days	69.05 Days	120.58 Days
5yr Average Interest Coverage Ratio	6.25	11.46	11.52
5yr Avg ROCE	6.7 %	10.86 %	6.65 %
5yr Avg Operating Profit Margin	6.07 %	13.88 %	17.76 %
5 yr average Debt to Equity	0.43	0.15	0.44
5yr CAGR Net Profit	22.48 %	n/a	-27.23 %
5yr Average Return on Assets	1.78 %	5.29 %	3.1 %
Shareholdings
Promoter Holding	75.26 %	43.72 %	44.23 %
Share Pledged by Promoters	0.0	0.01 %	7.92 %
Change in Promoter Holding (3 Yrs)	0.0	-2.26 %	-5.78 %
Change in Mutual Fund Holding (3 Yrs)	1.55 %	-4.21 %	3.04 %

Business

	Akums Drugs & Pharma	Aarti Pharmalabs	Shilpa Medicare
Product Wise Break-Up	Product Wise Break-Up CDMO 78.18 Branded and generic formulations 16.74 API 5.09 Xanthine derivatives & Intermediates 0 API and Intermediates 0 CMO/CDMO 0 Power sales 0 Pharmaceutical product and services 0	Product Wise Break-Up Power sales 0 API 38.8 Branded and generic formulations 0 CDMO 0 CDMO 26.9 Pharmaceutical product and services 0 API 0 Xanthine 34.3	Product Wise Break-Up Power sales 0 API and Intermediates 0 Branded and generic formulations 0 CDMO 0 CMO/CDMO 0 Pharmaceutical 100.0 API 0 Xanthine derivatives & Intermediates 0
Location Wise Break-Up	Location Wise Break-Up India 93.55 Outside India 6.45 Rest of the World 0 Europe 0 USA 0	Location Wise Break-Up India 49.0 USA 0 Europe 0 Outside India 0 Rest of the World 0 Others 51.0	Location Wise Break-Up India 5.26 USA 6.77 Europe 36.84 Outside India 0 Rest of the World 33.08 Others 18.05
Operating Profit Break-Up	Operating Profit Break-Up CDMO 88.08 Branded and generic formulations 11.92 API`s 0	-	-
Asset Break-Up - Segment Wise	Asset Break-Up - Segment Wise CDMO 76.41 API`s 14.71 Branded and generic formulations 8.88	-	-